MDMA-assisted therapy for trauma: revisiting the past, safely
In phase 3 trials, most people with severe PTSD no longer met the diagnostic criteria after MDMA-assisted therapy. Here's how it works, and where it stands with regulators.
Trauma is stubborn precisely because the mind protects itself: approaching the memory triggers so much fear that it's hard to process. MDMA-assisted therapy aims at exactly that obstacle.
How it helps
MDMA temporarily reduces activity in the brain's fear centre and increases feelings of trust and safety. In that state, guided by trained therapists, a person can revisit a traumatic memory without being overwhelmed by it, allowing the brain to finally process and re-file it.
What the trials found
In phase 3 trials for severe PTSD, a majority of participants who received MDMA-assisted therapy no longer met the diagnostic criteria for PTSD afterward: results strong enough to draw serious regulatory attention.
Where it stands
The picture is evolving: regulators have asked for additional data, so MDMA-assisted therapy is not yet broadly approved, though some countries (such as Australia) permit it under strict conditions. It remains investigational in most places.
The key distinction
This is therapy assisted by MDMA in a clinical setting: structured preparation, trained therapists, and integration afterward. It bears little resemblance to recreational use, which carries real risks and none of the therapeutic scaffolding.
Mura is educational only. We do not supply, prescribe, or recommend any substance. For trauma, a trained therapist (including EMDR or trauma-focused CBT) is the safe place to start.
This article is for general information and is not a substitute for professional care. If you are in crisis or thinking about harming yourself, please contact your local emergency services or a crisis line. See crisis lines.